Healthcare Services Group Valuation

Is HS1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HS1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: HS1 (€10.6) is trading below our estimate of fair value (€49.39)

Significantly Below Fair Value: HS1 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HS1?

Key metric: As HS1 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for HS1. This is calculated by dividing HS1's market cap by their current earnings.
What is HS1's PE Ratio?
PE Ratio	16.3x
Earnings	US$51.06m
Market Cap	US$832.59m

HS1 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.5x
Enterprise Value/EBITDA	11.5x
PEG Ratio	1x

Price to Earnings Ratio vs Peers

How does HS1's PE Ratio compare to its peers?

The above table shows the PE ratio for HS1 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	10.7x
CWC CEWE Stiftung KGaA	10.9x	2.3%	€691.9m
GBF Bilfinger	7.3x	2.3%	€1.7b
BFSA Befesa	12.9x	30.2%	€734.8m
AAD Amadeus FiRe	11.9x	7.2%	€411.8m
HS1 Healthcare Services Group	16.3x	16.2%	€832.6m

Price-To-Earnings vs Peers: HS1 is expensive based on its Price-To-Earnings Ratio (16.3x) compared to the peer average (10.8x).

Price to Earnings Ratio vs Industry

How does HS1's PE Ratio compare vs other companies in the European Commercial Services Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: HS1 is expensive based on its Price-To-Earnings Ratio (16.3x) compared to the European Commercial Services industry average (14.7x).

Price to Earnings Ratio vs Fair Ratio

What is HS1's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HS1 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	16.3x
Fair PE Ratio	11.2x

Price-To-Earnings vs Fair Ratio: HS1 is expensive based on its Price-To-Earnings Ratio (16.3x) compared to the estimated Fair Price-To-Earnings Ratio (11.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HS1 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	€10.60	€12.70 +19.8%	14.9%	€15.70	€11.08	n/a	4
Nov ’25	€9.95	€12.70 +27.6%	14.9%	€15.70	€11.08	n/a	4
Oct ’25	€9.90	€13.14 +32.7%	12.5%	€15.67	€11.06	n/a	4
Sep ’25	€9.65	€13.14 +36.1%	12.5%	€15.67	€11.06	n/a	4
Aug ’25	€10.40	€13.14 +26.3%	12.5%	€15.67	€11.06	n/a	4
Jul ’25	€9.70	€13.52 +39.4%	11.4%	€15.86	€12.13	n/a	4
Jun ’25	€9.75	€13.52 +38.7%	11.4%	€15.86	€12.13	n/a	4
May ’25	€10.00	€13.52 +35.2%	11.4%	€15.86	€12.13	n/a	4
Apr ’25	€11.40	€13.46 +18.1%	11.4%	€15.78	€12.07	n/a	4
Mar ’25	€11.60	€13.46 +16.1%	11.4%	€15.78	€12.07	n/a	4
Feb ’25	€8.60	€11.72 +36.3%	18.7%	€14.71	€9.20	n/a	4
Jan ’25	€9.25	€11.72 +26.7%	18.7%	€14.71	€9.20	n/a	4
Dec ’24	€8.80	€11.72 +33.2%	18.7%	€14.71	€9.20	n/a	4
Nov ’24	€8.85	€12.79 +44.5%	16.1%	€15.16	€9.47	€9.95	4
Oct ’24	€9.90	€14.74 +48.9%	9.4%	€16.85	€13.10	€9.90	4
Sep ’24	€10.60	€14.22 +34.2%	8.7%	€16.41	€12.77	€9.65	5
Aug ’24	€11.40	€14.22 +24.8%	8.7%	€16.41	€12.77	€10.40	5
Jul ’24	€13.70	€14.88 +8.6%	8.3%	€16.33	€12.70	€9.70	5
Jun ’24	€12.70	€14.88 +17.2%	8.3%	€16.33	€12.70	€9.75	5
May ’24	€14.20	€14.88 +4.8%	8.3%	€16.33	€12.70	€10.00	5
Apr ’24	€12.90	€14.25 +10.5%	10.4%	€16.73	€13.01	€11.40	6
Mar ’24	€12.40	€13.48 +8.7%	21.0%	€16.83	€7.95	€11.60	6
Feb ’24	€12.30	€12.97 +5.5%	21.3%	€17.19	€8.12	€8.60	6
Jan ’24	€11.30	€12.97 +14.8%	21.3%	€17.19	€8.12	€9.25	6
Dec ’23	€13.20	€15.28 +15.8%	30.0%	€24.33	€8.62	€8.80	7
Nov ’23	€14.10	€15.28 +8.4%	30.0%	€24.33	€8.62	€8.85	7

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.